Back to News
Market Impact: 0.15
Tenax Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights
Source: PR Newswire
Legal & LitigationHealthcare & Biotech
DJS Law Group reminded investors of a class action lawsuit against Tenax Therapeutics (NASDAQ: TENX), alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. The excerpt provides no further allegations, financial figures, or case developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
TENX-0.75
More News
- Berkshire shares surge as Wall Street swoons amid AI fears
- Paraguay’s ousted president charged over banking scandal
- Tech companies face mounting child safety lawsuits while pushing AI into schools
- argenx reports positive phase 3 data for autoimmune myositis drug
- U.S. intelligence memo ties Nvidia’s Huang to alleged Chinese spy, FT reports
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup